UnitedHealth Group (NYSE:UNH) Stock Price Down 0.3%

Shares of UnitedHealth Group Incorporated (NYSE:UNHGet Free Report) dropped 0.3% on Thursday . The stock traded as low as $491.28 and last traded at $492.80. Approximately 891,825 shares changed hands during trading, a decline of 78% from the average daily volume of 4,139,037 shares. The stock had previously closed at $494.23.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Barclays began coverage on UnitedHealth Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price for the company. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens reaffirmed an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Finally, Truist Financial reaffirmed a “buy” rating and set a $610.00 price target on shares of UnitedHealth Group in a research report on Thursday, November 30th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Get Our Latest Report on UnitedHealth Group

UnitedHealth Group Trading Down 0.3 %

The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company has a market cap of $451.75 billion, a P/E ratio of 20.55, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The stock has a 50-day moving average of $505.61 and a two-hundred day moving average of $518.05.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same quarter last year, the company earned $5.34 EPS. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio is 31.54%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

Large investors have recently made changes to their positions in the business. Kraft Davis & Associates LLC lifted its position in shares of UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after buying an additional 19 shares in the last quarter. Secure Asset Management LLC lifted its position in shares of UnitedHealth Group by 0.8% in the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after buying an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC increased its stake in UnitedHealth Group by 1.6% during the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after acquiring an additional 19 shares during the last quarter. Bensler LLC increased its stake in UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after acquiring an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX increased its stake in UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after acquiring an additional 19 shares during the last quarter. 85.69% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.